Approximately 80% of GIST have activating mutations in the KIT receptor tyrosine kinase gene and approximately 5–10% have activating mutations in the platelet-derived growth factor receptor alpha (PDGFRA) tyrosine kinase gene [2–4]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.